
    
      This study is designed to test the safety and feasibility of Autologous Muscle Derived Cells
      (AMDC) as a treatment for fecal incontinence in men and women. AMDC therapy seeks to allow
      remodeling of the external anal sphincter in patients with fecal incontinence from either
      defined structural defects to or a generalized weakening of the external anal sphincter.
    
  